Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice.

Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, Yamagoe S, Colnot S, Viguier M, Perret C, Couty JP.

J Clin Invest. 2012 Feb;122(2):586-99. doi: 10.1172/JCI43937.

2.

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.

Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, Sun S.

Hepatology. 2012 Nov;56(5):1631-40. doi: 10.1002/hep.25849.

PMID:
22610915
3.

Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.

Ovejero C, Cavard C, Périanin A, Hakvoort T, Vermeulen J, Godard C, Fabre M, Chafey P, Suzuki K, Romagnolo B, Yamagoe S, Perret C.

Hepatology. 2004 Jul;40(1):167-76.

PMID:
15239100
4.

Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.

Okabe H, Delgado E, Lee JM, Yang J, Kinoshita H, Hayashi H, Tsung A, Behari J, Beppu T, Baba H, Monga SP.

PLoS One. 2014 Jun 3;9(6):e98817. doi: 10.1371/journal.pone.0098817.

5.

Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.

Latasa MU, Salis F, Urtasun R, Garcia-Irigoyen O, Elizalde M, Uriarte I, Santamaria M, Feo F, Pascale RM, Prieto J, Berasain C, Avila MA.

PLoS One. 2012;7(12):e52711. doi: 10.1371/journal.pone.0052711.

6.

The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.

Trierweiler C, Blum HE, Hasselblatt P.

PLoS One. 2012;7(7):e40638. doi: 10.1371/journal.pone.0040638.

7.

Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.

Giera S, Braeuning A, Köhle C, Bursch W, Metzger U, Buchmann A, Schwarz M.

Toxicol Sci. 2010 May;115(1):22-33. doi: 10.1093/toxsci/kfq033.

8.

Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice.

Braeuning A, Singh Y, Rignall B, Buchmann A, Hammad S, Othman A, von Recklinghausen I, Godoy P, Hoehme S, Drasdo D, Hengstler JG, Schwarz M.

Histochem Cell Biol. 2010 Nov;134(5):469-81. doi: 10.1007/s00418-010-0747-1.

PMID:
20886225
9.

Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.

Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA.

Cancer Res. 2009 May 1;69(9):3764-71. doi: 10.1158/0008-5472.CAN-09-0014.

10.
11.

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21.

12.

DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.

Chen L, Li M, Li Q, Wang CJ, Xie SQ.

Mol Cancer. 2013 Dec 10;12:157. doi: 10.1186/1476-4598-12-157.

13.

Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.

Evason KJ, Francisco MT, Juric V, Balakrishnan S, Lopez Pazmino Mdel P, Gordan JD, Kakar S, Spitsbergen J, Goga A, Stainier DY.

PLoS Genet. 2015 Jul 2;11(7):e1005305. doi: 10.1371/journal.pgen.1005305.

14.

ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.

Ikuta T, Kobayashi Y, Kitazawa M, Shiizaki K, Itano N, Noda T, Pettersson S, Poellinger L, Fujii-Kuriyama Y, Taniguchi S, Kawajiri K.

Carcinogenesis. 2013 Jul;34(7):1620-7. doi: 10.1093/carcin/bgt083.

15.

Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells.

Li W, Huang X, Tong H, Wang Y, Zhang T, Wang W, Dai L, Li T, Lin S, Wu H.

PLoS One. 2012;7(10):e47040. doi: 10.1371/journal.pone.0047040.

16.
17.

APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.

Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, Rosty C, Abal M, El Marjou F, Smits R, Louvard D, Fodde R, Robine S.

Gastroenterology. 2006 Oct;131(4):1096-109. Erratum in: Gastroenterology. 2006 Dec;131(6):2029.

PMID:
17030180
18.

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.

Okabe H, Kinoshita H, Imai K, Nakagawa S, Higashi T, Arima K, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Ishiko T, Yoshizumi T, Beppu T, Monga SP, Baba H, Maehara Y.

PLoS One. 2016 Apr 21;11(4):e0152695. doi: 10.1371/journal.pone.0152695.

19.

Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.

Ueberham E, Glöckner P, Göhler C, Straub BK, Teupser D, Schönig K, Braeuning A, Höhn AK, Jerchow B, Birchmeier W, Gaunitz F, Arendt T, Sansom O, Gebhardt R, Ueberham U.

Mol Cancer Res. 2015 Feb;13(2):239-49. doi: 10.1158/1541-7786.MCR-14-0278-T.

20.

NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling.

Stancikova J, Krausova M, Kolar M, Fafilek B, Svec J, Sedlacek R, Neroldova M, Dobes J, Horazna M, Janeckova L, Vojtechova M, Oliverius M, Jirsa M, Korinek V.

Cell Signal. 2015 Feb;27(2):245-56. doi: 10.1016/j.cellsig.2014.11.008.

Items per page

Supplemental Content

Support Center